Back to Research Hub
DexCom, Inc.
DXCM
$78.19+1.57 (+2.05%)
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.
StreetsValue research for DexCom, Inc. (DXCM)
Members get the full report for DexCom, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.